|
HRP20020231A2
(en)
*
|
2002-03-18 |
2003-12-31 |
Pliva D D |
ISOSTRUCTURAL PSEUDOPOLYMORPHS OF 9-DEOXO-9a-AZA-9a-METHYL-9a-HOMOERYTHROMYCIN A
|
|
US5912331A
(en)
*
|
1991-03-15 |
1999-06-15 |
Merck & Co., Inc. |
Process for the preparation of 9-deoxo-9(Z)-hydroxyiminoerythromycin A
|
|
US5985844A
(en)
*
|
1992-03-26 |
1999-11-16 |
Merck & Co., Inc. |
Homoerythromycin A derivatives modified at the 4"-and 8A-positions
|
|
US5189159A
(en)
*
|
1992-04-02 |
1993-02-23 |
Merck & Co., Inc. |
8a-AZA-8a-homoerythromycin cyclic iminoethers
|
|
EP0539223A1
(en)
*
|
1991-10-25 |
1993-04-28 |
Ono Pharmaceutical Co., Ltd. |
Glycine derivative monosodium salt tetrahydrate having an inhibitory effect on elastase
|
|
US5215980A
(en)
*
|
1992-01-17 |
1993-06-01 |
Merck & Co., Inc. |
10-AZA-9-deoxo-11-deoxy-erythromycin A and derivatives thereof
|
|
US5210235A
(en)
*
|
1992-08-26 |
1993-05-11 |
Merck & Co., Inc. |
Methods of elaborating erythromycin fragments into amine-containing fragments of azalide antibiotics
|
|
US5332807A
(en)
*
|
1993-04-14 |
1994-07-26 |
Merck & Co., Inc. |
Process of producing 8A- and 9A-azalide antibiotics
|
|
CN1034734C
(zh)
*
|
1993-12-10 |
1997-04-30 |
北京市集才药物研究所 |
一种新的阿齐红霉素结晶及其制备方法
|
|
US5605889A
(en)
|
1994-04-29 |
1997-02-25 |
Pfizer Inc. |
Method of administering azithromycin
|
|
CZ292360B6
(cs)
|
1994-05-06 |
2003-09-17 |
Pfizer Inc. |
Dávkovací forma s řízeným uvolňováním obsahující azithromycin a způsob její výroby
|
|
ES2122905B1
(es)
*
|
1996-07-11 |
1999-11-16 |
Astur Pharma Sa |
Sintesis de 11,12-hidrogenoortoborato de 9-desoxo-9a-aza-11,12-desoxi-9a-metil-9a-homoeritromicina a. un procedimiento para la preparacion de 9-desoxo-9a-aza-9a-metil-9a-homoeritromicina a dihidrato (azitromicina dihidrato).
|
|
EP1437359B1
(en)
*
|
1997-10-16 |
2006-12-20 |
GlaxoSmithKline istrazivacki centar Zagreb d.o.o. |
Novel 3,6-Hemiketals from the Class of 9a-Azalides
|
|
US6861411B1
(en)
|
1997-12-02 |
2005-03-01 |
Pfizer, Inc. |
Method of treating eye infections with azithromycin
|
|
PT102130A
(pt)
*
|
1998-03-13 |
1999-09-30 |
Hovione Sociedade Quimica S A |
Processo de preparacao de dihidrato de azitromicina
|
|
TW546302B
(en)
*
|
1998-05-08 |
2003-08-11 |
Biochemie Sa |
Improvements in macrolide production
|
|
US6245903B1
(en)
*
|
1998-08-21 |
2001-06-12 |
Apotex, Inc. |
Azithromycin monohydrate isopropanol clathrate and methods for the manufacture thereof
|
|
EP1484062A1
(en)
*
|
1998-11-30 |
2004-12-08 |
Teva Pharmaceutical Industries Limited |
Crystalline azithromycin, process for manufacture and pharmaceutical compositions thereof
|
|
US6239113B1
(en)
|
1999-03-31 |
2001-05-29 |
Insite Vision, Incorporated |
Topical treatment or prevention of ocular infections
|
|
US7056893B2
(en)
|
1999-03-31 |
2006-06-06 |
Insite Vision, Inc. |
Topical treatment for prevention of ocular infections
|
|
DK1189912T3
(da)
*
|
1999-05-18 |
2008-06-30 |
Pfizer Prod Inc |
Nye krystallinske former af et makrolid antibiotikum
|
|
HRP20010956B1
(hr)
*
|
1999-06-29 |
2010-09-30 |
Biochemie S.A. |
Makrolidi
|
|
ES2177373B1
(es)
*
|
1999-11-26 |
2003-11-01 |
Astur Pharma Sa |
Preparacion de azitromicina en su forma no cristalina
|
|
IL150564A0
(en)
*
|
2000-01-04 |
2003-02-12 |
Teva Pharma |
Preparation method of azithromycin dihydrate
|
|
ES2162764B1
(es)
*
|
2000-05-17 |
2003-04-01 |
Ercros Ind Sa |
Forma polimorfica del dihidrato de azitromicina, y su procedimiento deobtencion.
|
|
WO2002010144A1
(es)
|
2000-07-25 |
2002-02-07 |
Laboratorio Silanes, S.A. De C.V. |
PROCESO PARA LA PREPARACION EN UN SOLO PASO DE 7,16-DIOXA-2-AZA-10-O-CLADINOSIL-12-O-DESOSAMINIL-4,5-DIHIDROXI-6-ETIL-3,5,9,11,13,15-HEXAMETILBICICLO[11.2.1]HEXADECA-1(2)-EN-8-ONA Y OBTENCION DE UNA FORMA NUEVA DE 9-DESOXO-9a-AZA-9a-METIL-9a-HOMOERITROMICINA A
|
|
ES2172417B1
(es)
*
|
2000-07-31 |
2003-09-16 |
Sint Quimica Sa |
Nueva forma mejorada de azitromicina monohidrato de menor higroscopicidad, procedimiento de preparacion y composiciones farmaceuticas que la comprenden.
|
|
AU2001280000A1
(en)
|
2000-08-23 |
2002-03-04 |
Jaweed Mukarram, Siddiqui Mohammed |
Process for preparation of anhydrous azithromycin
|
|
CN100341886C
(zh)
*
|
2000-11-27 |
2007-10-10 |
桑多斯股份公司 |
大环内酯类化合物的溶剂化物
|
|
HRP20030430B1
(hr)
*
|
2000-11-27 |
2011-11-30 |
Biochemie S.A. |
Makrolidni solvati
|
|
IN190080B
(enExample)
*
|
2001-01-29 |
2003-06-07 |
Alembic Ltd |
|
|
KR100491183B1
(ko)
|
2001-03-21 |
2005-05-25 |
한미약품 주식회사 |
아지트로마이신의 제조방법 및 이 방법에 사용되는9-데옥소-9에이-아자-9에이-호모에리트로마이신 에이의결정성 수화물
|
|
EP1671978A1
(en)
|
2001-05-22 |
2006-06-21 |
Pfizer Products Inc. |
New Cristal Form of Azithromycin
|
|
NZ529118A
(en)
|
2001-05-22 |
2005-10-28 |
Pfizer Prod Inc |
Crystal forms of azithromycin
|
|
US6861413B2
(en)
|
2001-05-22 |
2005-03-01 |
Pfizer Inc. |
Stable non-dihydrate azithromycin oral suspensions
|
|
YU8804A
(sh)
*
|
2001-08-21 |
2006-08-17 |
Pfizer Products Inc. |
Jedno-dozni azitromicin
|
|
CN1668282A
(zh)
|
2001-12-21 |
2005-09-14 |
辉瑞产品公司 |
可直接压制的阿齐霉素配方
|
|
JP2005515212A
(ja)
*
|
2001-12-21 |
2005-05-26 |
ファイザー・プロダクツ・インク |
アジスロマイシンの湿式造粒法
|
|
KR100676025B1
(ko)
*
|
2002-02-01 |
2007-01-29 |
화이자 프로덕츠 인코포레이티드 |
아지쓰로마이신의 건조 과립화 제제
|
|
US7376064B2
(en)
|
2002-02-25 |
2008-05-20 |
Samsung Electronics Co., Ltd. |
Method and apparatus for recording data on optical recording medium
|
|
ITMI20021209A1
(it)
*
|
2002-06-04 |
2003-12-04 |
Chemi Spa |
Processo di preparazione di azitromicina ad elevata purezza
|
|
US6855813B2
(en)
*
|
2002-07-19 |
2005-02-15 |
Alembic Limited |
Process for the preparation of azithromycin monohydrate
|
|
HRP20020614A2
(en)
|
2002-07-22 |
2004-06-30 |
PLIVA-ISTRAŽIVAČKI INSTITUT d.o.o. |
Rhombic pseudopolymorph of 9-deoxo-9a-aza-9a-methyl-9a-homoerythromycin a
|
|
GB2395482A
(en)
*
|
2003-07-03 |
2004-05-26 |
Jubilant Organosys Ltd |
Process for preparing non-hygroscopic azithromycin dihydrate
|
|
US20050013835A1
(en)
*
|
2003-07-15 |
2005-01-20 |
Pfizer Inc. |
Stable non-dihydrate azithromycin oral suspensions
|
|
WO2005053639A2
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Controlled release multiparticulates formed with dissolution enhancers
|
|
KR20060092281A
(ko)
*
|
2003-12-04 |
2006-08-22 |
화이자 프로덕츠 인크. |
액체 기초 방법에 의한 아지트로마이신 복합입자 투여형
|
|
DK1691787T3
(da)
*
|
2003-12-04 |
2008-09-22 |
Pfizer Prod Inc |
Fremgangsmåde til at danne småpartikler
|
|
WO2005053652A1
(en)
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Multiparticulate crystalline drug compositions containing a poloxamer and a glyceride
|
|
BRPI0417348A
(pt)
*
|
2003-12-04 |
2007-03-13 |
Pfizer Prod Inc |
processo de gelatinização por spray com utilização de uma extrusora para preparação de composições de droga cristalina multiparticulada contendo preferencialmente um poloxámero e um glicerìdeo
|
|
US6984403B2
(en)
*
|
2003-12-04 |
2006-01-10 |
Pfizer Inc. |
Azithromycin dosage forms with reduced side effects
|
|
CA2547597A1
(en)
*
|
2003-12-04 |
2005-06-16 |
Pfizer Products Inc. |
Multiparticulate compositions with improved stability
|
|
RU2006119464A
(ru)
*
|
2003-12-04 |
2007-12-20 |
Пфайзер Продактс Инк. (Us) |
Способ распыления-охлаждения с применением экструдера для получения композиций азитромицина в мультичастицах, предпочтительно содержащих полоксамер и глицерид
|
|
RU2260012C1
(ru)
*
|
2004-01-29 |
2005-09-10 |
Открытое акционерное общество "Акционерное курганское общество медицинских препаратов и изделий "Синтез" |
Способ кристаллизации азитромицина дигидрата
|
|
US20060116336A1
(en)
*
|
2004-03-17 |
2006-06-01 |
American Pharmaceutical Partners, Inc. |
Lyophilized azithromycin formulation
|
|
US7468428B2
(en)
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
|
WO2006011160A1
(en)
|
2004-06-28 |
2006-02-02 |
Alembic Limited |
Process for the preparation of azithromycin monohydrate isopropanol clathrate
|
|
CN1308361C
(zh)
*
|
2004-08-09 |
2007-04-04 |
大连振邦氟涂料股份有限公司 |
乙烯－三氟氯乙烯共聚物的制备方法
|
|
US7683162B2
(en)
*
|
2004-08-30 |
2010-03-23 |
Taro Pharmaceutical Industries Limited |
Process of preparing a crystalline azithromycin monohydrate
|
|
US7439252B2
(en)
*
|
2004-12-01 |
2008-10-21 |
TEVA Gyógyszergyár Zártkörúen Müködö Részvénytársaság |
Ascomycin crystalline forms and preparation thereof
|
|
WO2006067576A1
(en)
*
|
2004-12-21 |
2006-06-29 |
Pfizer Products Inc. |
Enteric coated azithromycin multiparticulates
|
|
US8546423B2
(en)
|
2005-05-18 |
2013-10-01 |
Mpex Pharmaceuticals, Inc. |
Aerosolized fluoroquinolones and uses thereof
|
|
CN100366686C
(zh)
*
|
2006-01-12 |
2008-02-06 |
济南瑞氟化工科技有限公司 |
一种氟硅超双疏不粘涂料
|
|
CA2654450A1
(en)
*
|
2006-06-05 |
2007-12-13 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted erythromycin analogs
|
|
US7704959B2
(en)
|
2006-10-03 |
2010-04-27 |
Dow Pharmaceutical Sciences |
Azithromycin for the treatment of nodular acne
|
|
US20090062220A1
(en)
*
|
2007-08-29 |
2009-03-05 |
Protia, Llc |
Deuterium-enriched azithromycin
|
|
CN101177441B
(zh)
*
|
2007-12-05 |
2012-05-23 |
浙江耐司康药业有限公司 |
一种稳定的阿奇霉素一水合物结晶的制备方法
|
|
CN101624412B
(zh)
*
|
2008-07-10 |
2012-07-04 |
刘力 |
大环内酯类衍生物及其制备和用途
|
|
EP2344129B1
(en)
|
2008-10-07 |
2018-02-21 |
Horizon Orphan LLC |
Aerosol fluoroquinolone formulations for improved pharmacokinetics
|
|
PL2346509T3
(pl)
|
2008-10-07 |
2021-03-08 |
Horizon Orphan Llc |
Lewofloksacyna w postaci aerozolu dla zmniejszania stanu zapalnego płuc
|
|
CN101418026B
(zh)
*
|
2008-10-09 |
2011-05-18 |
南京工业大学 |
一种晶型和粒度可控的阿奇霉素结晶工艺
|
|
CN101787063B
(zh)
*
|
2009-01-23 |
2012-12-19 |
刘力 |
抗感染药物及其制备和用途
|
|
WO2010103119A1
(en)
|
2009-03-13 |
2010-09-16 |
Da Volterra |
Compositions and methods for elimination of gram-negative bacteria
|
|
CA2938650C
(en)
|
2009-09-04 |
2018-01-09 |
Raptor Pharmaceuticals Inc. |
Use of aerosolized levofloxacin for treating cystic fibrosis
|
|
CN102911219A
(zh)
*
|
2011-08-03 |
2013-02-06 |
山东方明药业集团股份有限公司 |
一种阿齐霉素在水相直接结晶的方法
|
|
CN103159811A
(zh)
*
|
2011-12-10 |
2013-06-19 |
山东方明药业集团股份有限公司 |
一种阿齐霉素中间体9a-脱氧-9a-氮杂-9a-高红霉素A的制备方法
|
|
WO2013088274A1
(en)
|
2011-12-14 |
2013-06-20 |
Wockhardt Limited |
Anhydrous amorphous azithromycin composition free of azithromycin dihydrate
|
|
CN102417531B
(zh)
*
|
2011-12-20 |
2014-06-11 |
浙江国邦药业有限公司 |
一种阿奇霉素一水合物的制备方法
|